Margaret Fischl

Division of Infectious Diseases, Miller School of Medicine, University of Miami

Affiliated withMiller School of Medicine, University of Miami

Research Area

Biography

Margaret Fischl has not added Biography.
If you are Margaret Fischl and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2017

Other Publications

Article	Year
Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 11797179	2002
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy. Antiviral therapy\| PubMed ID: 12008787	2002
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milli... Journal of clinical microbiology\| PubMed ID: 12037070	2002
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA : the journal of the American Medical Association\| PubMed ID: 12095387	2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359. The Journal of infectious diseases\| PubMed ID: 12195349	2002
Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 12473835	2002
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects. Antimicrobial agents and chemotherapy\| PubMed ID: 12760869	2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease. The Journal of infectious diseases\| PubMed ID: 12934177	2003
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 14523778	2003
Twice-daily Trizivir versus Combivir-abacavir in antiretroviral-experienced adults with human immunodeficiency virus-1 infection: a formulation-switch trial. Pharmacotherapy\| PubMed ID: 14620390	2003
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. The New England journal of medicine\| PubMed ID: 14668455	2003
Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease. The Journal of infectious diseases\| PubMed ID: 14745710	2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antiviral therapy\| PubMed ID: 14760884	2003
Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects. Antimicrobial agents and chemotherapy\| PubMed ID: 14982784	2004
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA : the journal of the American Medical Association\| PubMed ID: 15249575	2004
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 15356820	2004
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. Clinical pharmacokinetics\| PubMed ID: 15634033	2005
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse ... Antimicrobial agents and chemotherapy\| PubMed ID: 16048984	2005
A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. The Journal of infectious diseases\| PubMed ID: 16170757	2005
Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 16394845	2006
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA : the journal of the American Medical Association\| PubMed ID: 16905788	2006
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Topics in HIV medicine : a publication of the International AIDS Society, USA\| PubMed ID: 17016878	2006
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). The Journal of infectious diseases\| PubMed ID: 17109338	2006
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. AIDS (London, England)\| PubMed ID: 17255739	2007
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Therapeutic drug monitoring\| PubMed ID: 17304157	2007
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV. Pharmacogenomics\| PubMed ID: 17324111	2007
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users. Journal of pharmaceutical and biomedical analysis\| PubMed ID: 17391891	2007
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective rando... Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 17527093	2007
Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection. Clinical drug investigation\| PubMed ID: 17535038	2003
Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study. AIDS patient care and STDs\| PubMed ID: 17711380	2007
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Therapeutic drug monitoring\| PubMed ID: 17898644	2007
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy. Antiviral therapy\| PubMed ID: 17926654	2007
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions\| PubMed ID: 18058416	2007
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected... HIV clinical trials\| PubMed ID: 18215978	2008
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT. AIDS research and therapy\| PubMed ID: 18373851	2008
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA\| PubMed ID: 18677028	2008
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults. The Journal of infectious diseases\| PubMed ID: 18771406	2008
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood\| PubMed ID: 19380868	2009
The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 19935211	2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. The New England journal of medicine\| PubMed ID: 19952143	2009
Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients. AIDS research and human retroviruses\| PubMed ID: 20380480	2010
Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 20463584	2010
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy. AIDS (London, England)\| PubMed ID: 21124203	2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV clinical trials\| PubMed ID: 21239359	2010
Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes. Vaccine\| PubMed ID: 21241732	2011
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Annals of internal medicine\| PubMed ID: 21320923	2011
Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral the... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21531891	2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders. Therapeutic drug monitoring\| PubMed ID: 21544014	2011
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients. The Journal of allergy and clinical immunology\| PubMed ID: 21752440	2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. The Journal of infectious diseases\| PubMed ID: 21917892	2011
Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine. Blood\| PubMed ID: 22692510	2012
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202. The Journal of infectious diseases\| PubMed ID: 23148286	2013
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status. The Journal of infectious diseases\| PubMed ID: 23148287	2012
Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study. PloS one\| PubMed ID: 23724003	2013
Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection. The Journal of infectious diseases\| PubMed ID: 23922374	2013
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 24046302	2013
Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PloS one\| PubMed ID: 24236161	2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 24253247	2014
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202. HIV clinical trials\| PubMed ID: 24334181	2013
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS pathogens\| PubMed ID: 24497828	2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. The Lancet. Infectious diseases\| PubMed ID: 24525316	2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. The Journal of antimicrobial chemotherapy\| PubMed ID: 25159623	2014
HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine. The Journal of infectious diseases\| PubMed ID: 25556252	2015
Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 26187020	2015
A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health. BMJ open\| PubMed ID: 26553833	2015
Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women. American journal of reproductive immunology (New York, N.Y. : 1989)\| PubMed ID: 26666220	2016
Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral... Journal of virology\| PubMed ID: 26676775	2015
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders. Current vascular pharmacology\| PubMed ID: 26733388	2016
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 26908786	2016
A therapeutic HIV-1 vaccine enhances anti-HIV-1 immune responses in patients under highly active antiretroviral therapy. Vaccine\| PubMed ID: 27002500	2016
Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study. PloS one\| PubMed ID: 27078021	2016
Behaviorally and perinatally HIV-infected young women: targets for preconception counseling. AIDS care\| PubMed ID: 27535165	2017
Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease. AIDS (London, England)\| PubMed ID: 27835618	2017
High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV S... AIDS research and human retroviruses\| PubMed ID: 27897054	2017
Smoking, HIV, and risk of pregnancy loss. AIDS (London, England)\| PubMed ID: 27902507	2017